REGAIN CONTROL WITH PERSONALIZED MUSCLE REGENERATION

muvon_therapeutics_icon.png

MEET MUVON

OUR STORY

MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a cell therapy platform for the regeneration of skeletal muscle tissue, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life.

OUR VISION

Together, we aim to establish personalized, regenerative treatments as the primary standard of care. Our goal is to help the millions of patients suffering from seriously debilitating diseases to regain control over their life by offering them minimally invasive, low-risk treatments for the regeneration of skeletal muscle tissue.

OUR TECHNOLOGY

MUVON Therapeutics is developing an autologous cell therapy platform for the treatment of diseases related to skeletal muscle damage or degradation. Our technology enables the targeted isolation of muscle precursor cells (MPCs) from muscle tissue, the controlled expansion of these cells and the regeneration of muscle tissue through injection of the expanded cells.

We are recruiting patients for our phase II clinical trial to treat stress urinary incontinence in women

SUPPORT &
AWARDS

Wyss-no-background.png
uzh_logo_e_pos.png
TDA_lkd.png
WSS_Logo_16mm_600_rgb.png
BEI_Logo_byline_RGB.png
USZ-Logo_quer_Blau_RGB.png
Venture lab.png
co-funded-h2020-horiz_en.png
2021_VEN_Finalist_h&n_pos_RGB.png
Innosuisse.png
Lichtsteiner.png
 

INTERESTED IN INVESTING ?

Interested in investing in this innovative regenerative therapy?